Target intelligence / Profile preview

DEAD box polypeptide 25 pseudogene

Molecular classification
Other
01

Overview

The term "DEAD box polypeptide 25 pseudogene" refers to a non-protein-coding pseudogene related to the DEAD-box helicase 25 (DDX25) gene. Pseudogenes are remnants of genes that have lost their protein-coding ability or are otherwise nonfunctional, often due to mutations. They may sometimes have regulatory functions at the RNA level, including potential roles in generating small RNAs, but they do not produce a functional protein product and are generally not considered valid therapeutic targets[4]. Clarification and Context: - The Ensembl identifier ENSG00000251682 specifically designates a pseudogene, not the active, protein-coding DDX25 gene (which is ENSG00000109832)[1]. - Pseudogenes are conventionally not considered therapeutic targets because they do not encode functional proteins; thus, there are no known disease associations, molecular functions, direct drug interactions, or established roles as biomarkers for this pseudogene[1][4]. - While the DDX25 protein itself is an RNA helicase with recognized biological functions, its pseudogene ("DEAD box polypeptide 25 pseudogene") does not share these properties or clinical relevance[1][3]. - Specifying the pseudogene as the target appears to be either a mistake, a misannotation, or a non-canonical approach for therapeutic targeting. Therefore, this entry should be flagged as is_incorrect: true, since it is not a standard or meaningful drug discovery or therapeutic entity. Summary Statement: The queried target, "DEAD box polypeptide 25 pseudogene" (ENSG00000251682), is a pseudogene and is not a protein-coding gene, receptor, enzyme, or other typical therapeutic target. It should not be used where active targets are required in biomedical applications or drug discovery[1][4].

Beyond the preview

Go deeper on DEAD box polypeptide 25 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEAD box polypeptide 25 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call